期刊文献+

Ahmed青光眼引流阀治疗新生血管性青光眼的临床疗效 被引量:19

Clinical efficacy of Ahmed glaucoma valve implantation in neovascular glaucoma
下载PDF
导出
摘要 目的:评价Ahmed青光眼引流阀治疗新生血管性青光眼的临床效果。方法:回顾性病例研究。收集2011-01/2012-12住院行Ahmed青光眼引流阀植入术治疗的28例28眼新生血管性青光眼患者临床资料,进行回顾性分析。患者随访时间为术后1d;1wk;1,3,6mo及之后的每6mo随访1次。随访内容主要包括患者术后眼压、最佳矫正视力、应用抗青光眼药物种类数及并发症等。术后不同时间点的眼压比较采用重复测量资料的方差分析,手术前后应用抗青光眼药物种类数比较采用秩和检验,术前与末次随访视力比较采用等级资料秩和检验。结果:不同时间点的眼压比较差异有统计学意义(F=11.23,P<0.05)。术前平均应用抗青光眼药物4.12±0.23种,术后平均应用抗青光眼药物0.56±0.11种,手术前后比较差异有统计学意义(Z=9.224,P<0.05)。术前与末次复查视力比较,差异无统计学意义(Z=-1.922,P>0.05)。Ahmed引流阀植入术完全成功率71%,条件成功率86%。术后并发症主要包括引流盘周围包裹性囊状泡、浅前房、低眼压对症处理后眼压均可控制。结论:Ahmed青光眼引流阀植入术是新生血管性青光眼的安全、有效治疗方式之一。 AIM : To evaluate the efficacy of Ahmed glaucoma valve implantation in neovascular glaucoma (NVG). METHODS: This retrospective study collected a total of 28 eyes of 28 neovascular glaucoma patients who underwent Ahmed glaucoma valve implantation in our hospital from January 2011 to December 2012. Change of intraocular pressure, the best corrected visual acuity, numbers of anti-glaucoma medication and postoperative complications were followed up at ld, lwk, 1, 3, 6too, and every 6 months after surgery. Data were analyzed by repeated measures analysis of variance for comparison of intraocular pressure between different time points, rank sum test for paired nonparametric numbers of medication, and rank sum test for visual acuity between pre-operation and the last following-up. RESULTS: Compared with the pre- operation, the intraocular pressure was significant decreased after surgery at all time points (F= 11. 23, P〈 0. 05). The numbers of anti-glaucoma medication were significant reduced from 4.12_+0.23 of pre-operation to 0.56_+0.11 of postoperative (Z= 9. 224, P〈0.05). The visual acuity was not significant difference between pre-operation and the last following-up (Z=-l. 922, P〉0. 05). At the last following-up, the complete success rate was 71%, and qualified success rate was 86%. The postoperative complications including encapsulated cystic blebs around the plate, shallow anterior chamber and low intraocular pressure were controlled with additional treatment. CONCLUSION: Ahmed glaucoma valve implantation is safe and effective in the management of neovascular glaucoma.
作者 孙重 吴作红
出处 《国际眼科杂志》 CAS 2014年第2期243-245,共3页 International Eye Science
关键词 青光眼引流植入物 青光眼 新生血管性 治疗效果 glaucoma drainage implants glaucoma neovascular treatment outcome
  • 相关文献

参考文献10

  • 1Katz GJ, Higgiubotham E J, Lichter PR, et al. Mitomycin C versus 5- fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 1995 ; 102 ( 9 ) : 1263-1269 3.
  • 2Sarkisian SR Jr. Tube shunt complications and their prevention. Curr Opin Ophthalmol 2009 ; 20 ( 2 ) : 126-130 4.
  • 3Wishart PK, Choudhary A, Wong D. Ahmed glaucoma valves in refractory glaucoma-a seven year audit. Br J Ophthalmol 2010 ;94 (9) : 1174-1179 5.
  • 4Alvarado JA, Hollander DA, Juster RP, et al. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol 2008 ; 146 ( 2 ) :276-284.
  • 5王宁利,高汝龙,唐仕波,吴河坪,曾明兵.三种途径植入房水引流物治疗难治性青光眼的疗效观察[J].中华眼科杂志,2001,37(6):409-413. 被引量:27
  • 6Lai JS, Poon AS, Chua JK, et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol 2000;84(7) :718-721.
  • 7陈虹,张舒心,刘磊,唐忻,孙丽,林丁,王宁利.Ahmed青光眼阀植入术后高眼压原因分析及处理[J].眼科,2004,13(4):201-205. 被引量:13
  • 8Hong CH, Arosemena A, Zurakowski D, et al. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005 ; 50 ( 1 ) :48-60 10.
  • 9Tai MC, Cheng JH,Chen JT, et al. Intermediate outcomes of Ahmed glaucoma valve surgery in Asian patients with intractable glaucoma. Eye 2010; 24(4) :547-552 11.
  • 10Huang MC, Netland PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999 ; 127( 1 ) :27-33.

二级参考文献19

  • 1吴瑜瑜.青光眼引流性植入物的研究进展[J].国外医学(眼科学分册),1996,20(4):228-232. 被引量:13
  • 2Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant [J]. Am J Ophthalmol, 1999,128:198-204.
  • 3Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve [J]. Am J Ophthalmol,2003,136: 1001-1008.
  • 4Colemen AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed glaucoma valve implant [J].Am J Ophthalmol, 1995,120:23-31.
  • 5Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma [J]. Ophthalmololgy, 1998,105:1968-1976.
  • 6Ayyala RS, Michelini-Norris B, Flores A, et al. Comparison of different biomaterials for glaucoma drainage devices part 2 [J]. Arch Ophthalmol, 2000 , 118 (8):1081-1084.
  • 7Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? [J] Ophthalmology, 1992,99:1512-1519.
  • 8Lloyd MA, Baerveldt G, Fellenbaum PS, et al. Intermediateterm results of a randomized clinical trial of the 350-versus the 500-mm2 Baerveldt implant [J]. Ophthalmology, 1994,101:1456-1464.
  • 9Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma [J]. JOcul Pharmacol, 1990, 6:175-182.
  • 10Huang MC, Netland PA, Coleman AL, et al. Intermediteterm clinicalexperience with the Ahmed glaucoma valva implant [J]. Am J Ophthalmol, 1999,127:27-33.

共引文献33

同被引文献133

引证文献19

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部